As a type of immunotherapy, the PD-1 blocking monoclonal antibodies act directly on immune cells and block the inhibitory T-cell receptor PD-1, and have also been proven to be effective for the treatment of liver cancer (4). The gene discussed is PDCD1; the disease is liver cancer.